Episode 13: How academia and start-ups can accelerate the drug development pipeline with Pam Randhawa, CEO of Empiriko
The life sciences industry is seeing the convergence of some revolutionary technology, but is it bringing the right people together? Pam Randhawa, CEO and founder of Empiriko, stops by to chat about the need for closer collaboration across the biopharma space—between big and small organizations, academic institutions and startups, and the public and private sectors. Pam and Justin discuss the mutual benefits of partnerships between new and established biopharma organizations, academia’s untapped potential in life sciences R&D, and why Massachusetts is the model for cross-sector collaboration and innovation.
Plus, Pam answers some of Justin’s most pressing questions: How are biological models shaping clinical care? What can biopharma entrepreneurs learn from a 20-year industry veteran? And what will it take to make the Commonwealth the world’s No. 1 life sciences innovator?
To learn more about Definitive Healthcare, please visit us at definitivehc.com
